Rational design of the first difluorostatone-based PfSUB1 inhibitors-Reference-Cited by-同舟云学术

Rational design of the first difluorostatone-based PfSUB1 inhibitors

Published:2014-08 Issue:15 Volume:24 Page:3582-3586
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Giovani Simone,Penzo Maria,Brogi Simone,Brindisi Margherita,Gemma Sandra,Novellino Ettore,Savini Luisa,Blackman Michael J.,Campiani Giuseppe,Butini Stefania

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference30 articles.

1. Protease-Activated Receptor 1 Inhibition by SCH79797 Attenuates Left Ventricular Remodeling and Profibrotic Activities of Cardiac Fibroblasts

2. Malaria Chemotherapy: Recent Advances in Drug Development

3. Resisting resistance: dealing with the irrepressible problem of malaria

4. If Artemisinin Drugs Fail, What's Plan B?

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluorinating electrophilic interception in the oxidation or protonation of alkynyl tetracoordinate borons;Chem;2024-08

2. Peptidic Boronic Acid Plasmodium falciparum SUB1 Inhibitors with Improved Selectivity over Human Proteasome;Journal of Medicinal Chemistry;2024-07-25

3. Insights from structure-activity relationships and the binding mode of peptidic α-ketoamide inhibitors of the malaria drug target subtilisin-like SUB1;European Journal of Medicinal Chemistry;2024-04

4. Asymmetric difluoroalkylation via Michael addition of an in situ generated difluoroenol intermediate;Organic Chemistry Frontiers;2024

5. In Silico Identification of Natural Products and World-Approved Drugs Targeting the KEAP1/NRF2 Pathway Endowed with Potential Antioxidant Profile;Computation;2023-12-16